GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors

$507,168
Victor H. Engelhard · University Of Virginia · R01 · FY2023 · CA

Manipulating microenvironment and vasculature to enhance T cell infiltration into tumors

$507,168
Victor H. Engelhard · University Of Virginia · R01 · FY2022 · CA

Metabolic approaches to treat severe viral and inflammatory diseases

$507,085
Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2013 · AI

High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer

$507,028
Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2019 · CA

Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis

$507,004
Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2024 · CA

Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC)on Immunotherapy

$506,985
Despina Kontos · Columbia University Health Sciences · R01 · FY2025 · CA

Mechanisms of Epigenetic Plasticity in PDAC

$506,890
Chunling Yi · Georgetown University · R01 · FY2021 · CA

Therapeutic targeting of glutamine metabolism in MDS

$506,879
Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA

Role of immune regulation in colorectal cancer chemotherapeutic response

$506,854
Jun Lu · Yale University · R01 · FY2021 · CA

Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy

$506,843
Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · CA

Contributions of the Adipose Tissue to the Development of Pancreatic Cancer

$506,842
Zobeida Cruz-Monserrate · Ohio State University · R01 · FY2024 · CA

Targeting bidirectional signaling in lung stroma and cancer cells

$506,795
Uwe Rix · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA

Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes

$506,783
Mark A Atkinson · University Of Florida · R01 · FY2022 · DK

Myofibroblasts in Gastrointestinal Cancers

$506,773
Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2014 · CA

Mechanisms of immunosuppression in the development and progression of renal disease in Tuberous Sclerosis Complex

$506,772
Elizabeth P Henske · Brigham And Women'S Hospital · R01 · FY2024 · DK

Metabolic Control of Immune Suppression in Gliomas

$506,747
Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2015 · NS

Pathogenic reciprocal interplay between cyst epithelium and myofibroblasts in polycystic kidney disease

$506,706
Reena Rao · University Of Kansas Medical Center · R01 · FY2023 · DK

Age-related shifts in epithelial lineages and tissue homeostasis in mammary gland

$506,667
Mark A Labarge · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2012 · AG

Nanocage-based systemic delivery of TGFβ trap for immunomodulation of brain neoplasms

$506,606
Jung Soo Suk · Johns Hopkins University · R01 · FY2021 · NS

The identification of human hepatocellular carcinoma metastasis genes

$506,599
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Molecular signatures for liver cancer diagnosis and treatment stratification

$506,599
Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Defining the molecular determinants of inflammatory memory in the pancreas

$506,546
Rohit Chandwani · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DK

Defining the molecular determinants of inflammatory memory in the pancreas

$506,546
Rohit Chandwani · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DK

Exploring metabolic governance of immune cell form and function

$506,488
Daniel Puleston · Icahn School Of Medicine At Mount Sinai · DP2 · FY2024 · AI

Exploring metabolic governance of immune cell form and function

$506,488
Daniel Puleston · Icahn School Of Medicine At Mount Sinai · DP2 · FY2025 · AI